NWBO is in late stage 3 trial with their brain cancer vaccine (DCVax-L) and is under a massive short attack. The scenario playing in my head is, that in the current price a failure of the trial is already counted in - So any positive news from that trial could take this to the sky (short squeeze). A lot of bashing going on here, but what I'm seeing here is a technologi in cancer treatment with no side effects and a possible cure - To that price, I'm taking a chance. Another stock with similar technologi is ARGOS. Do your D D and read up before making an entry, you could lose your $$ investing in this one.
doesn't work here, it's wild and crazy stock.
Disclaimer: Don't buy without doing any D D, analyze it and follow your strategy. This is a massive risk, but I have bought a small portion of 20k stocks anyway at 0,55.
The 21st Century Cures Act invests $1.8 billion to help us end cancer as we know it. For over a year, I've been leading our National Cancer Moonshot to fundamentally change the culture of our fight against cancer and inject a sense of urgency into it. This bill goes a long way to help us -- investing in promising new therapies, enhancing prevention and detection efforts in every community regardless of zip code, and bringing us closer to the day when there are vaccines for all kinds of cancer, just as we have them for measles or mumps.
Read their PR here: https://www.nwbio.com/nw-bio-announces-lifting-clinical-hold-dcvax-l-phase-iii-trial-fda-progression-free-survival-events-reached-overall-survival-events-not-yet-reached/